scholarly journals Maternal gut microbiota is associated with newborn anthropometrics in a sex-specific manner

2019 ◽  
Vol 10 (6) ◽  
pp. 659-666 ◽  
Author(s):  
Yumi Sato ◽  
Kenichi Sakurai ◽  
Hiromi Tanabe ◽  
Tamotsu Kato ◽  
Yumiko Nakanishi ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Head Circumference ◽  
Univariate Analysis ◽  
Positive Association ◽  
Short Chain Fatty Acids ◽  
Foetal Growth ◽  
Specific Effects ◽  
Mother And Child ◽  
Health And Disease ◽  
Stool Samples

AbstractMaternal gut microbiota is thought to be one of the important factors in the developmental origins of health and disease (DOHaD) concept, but the effects of maternal gut microbiota on foetal growth are not well known. In this study, the association between maternal gut microbiota and foetal growth was investigated. Maternal and newborn information, as well as stool samples at the third trimester of pregnancy, were obtained from 51 mother–newborn pairs from the Chiba study of Mother and Child Health (C-MACH). Gut microbiota was analysed by 16S rRNA sequencing of stool samples and short-chain fatty acids (SCFAs) in stool were analysed by gas chromatography-tandem mass spectrometry. After adjustment for covariates, it was found that maternal gut microbial diversity had a positive association with head circumference in newborn males (Chao 1: adjusted r = 0.515, p = 0.029). Genus Parabacteroides and genus Eggerthella showed negative associations with newborn head circumference and weight, respectively in males (genus Parabacteroides: adjusted r = −0.598, p = 0.009, genus Eggerthella: adjusted r = −0.481, p = 0.043). On the other hand, genus Streptococcus showed a negative association with newborn height in females (adjusted r = −0.413, p = 0.040). In addition, hexanoate was involved in the association between maternal gut microbiota and newborn anthropometrics in the univariate analysis, but not in the multivariate analysis. These data suggest that maternal gut microbiota has sex-specific effects on foetal growth. Maternal gut microbiota is an important factor for optimal intrauterine growth.

scholarly journals Bacterial Taxa Associated with High Adherence to Mediterranean Diet in a Spanish Population

Proceedings ◽  
2020 ◽  
Vol 61 (1) ◽  
pp. 10
Author(s):  
Carles Rosés ◽  
Amanda Cuevas-Sierra ◽  
Salvador Quintana ◽  
José I. Riezu-Boj ◽  
J. Alfredo Martínez ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Dietary Intake ◽  
Mediterranean Diet ◽  
Dietary Habits ◽  
Metabolic Diseases ◽  
Positive Association ◽  
Normal Weight ◽  
Statistical Tool ◽  
High Adherence ◽  
Health And Disease

The Mediterranean diet (MD) is recognised as one of the healthiest diets worldwide and is associated with the prevention of cardiovascular and metabolic diseases, among others. Dietary habits are considered one of the strongest modulators of the gut microbiota, which seems to play a significant role in the health and disease of the host. The purpose of the present study was to evaluate interactive associations between gut microbiota composition and habitual dietary intake in 360 Spanish adults of the Obekit cohort (normal weight, overweight and obese subjects). Dietary intake and adherence to the MD tests together with faecal samples were collected from each subject. Faecal 16S rRNA sequencing was performed and checked against the dietary habits. MetagenomeSeq was the statistical tool applied to analyse at the species taxonomic level. Results from this study confirm that a strong adherence to the MD increases the population of some beneficial bacteria, improving microbiota status towards a healthier pattern. Bifidobacterium animalis is the species with the strongest association with the MD. One of the highlights is the positive association between several SCFA-producing bacteria and high adherence to the MD. In conclusion, this study shows that MD, fibre, legumes, vegetables, fruit and nuts intakes are associated with an increase in butyrate-producing taxa such as Roseburia faecis, Ruminococcus bromii and Oscillospira (Flavonifractor) plautii.

scholarly journals Longitudinal Multi-Omics Study of a Mother-Infant Dyad from Breastfeeding to Weaning: An Individualized Approach to Understand the Interactions Among Diet, Fecal Metabolome and Microbiota Composition

2021 ◽  
Vol 8 ◽  
Author(s):  
Giorgia Conta ◽  
Federica Del Chierico ◽  
Sofia Reddel ◽  
Federico Marini ◽  
Fabio Sciubba ◽  
...  
Keyword(s):  
Breast Milk ◽  
Gut Microbiota ◽  
Single Mother ◽  
Critical Role ◽  
Short Chain Fatty Acids ◽  
Lactation Period ◽  
Common Component ◽  
Sequence Of Events ◽  
16S Rna ◽  
Stool Samples

The development of the human gut microbiota is characterized by a dynamic sequence of events from birth to adulthood, which make the gut microbiota unique for everyone. Its composition and metabolism may play a critical role in the intestinal homeostasis and health. We propose a study on a single mother-infant dyad to follow the dynamics of an infant fecal microbiota and metabolome changes in relation to breast milk composition during the lactation period and evaluate the changes induced by introduction of complementary food during the weaning period. Nuclear Magnetic Resonance (NMR)-based metabolomics was performed on breast milk and, together with 16S RNA targeted-metagenomics analysis, also on infant stool samples of a mother-infant dyad collected over a period running from the exclusive breastfeeding diet to weaning. Breast milk samples and neonatal stool samples were collected from the 4th to the 10th month of life. Both specimens were collected from day 103 to day 175, while from day 219–268 only stool samples were examined. An exploratory and a predictive analysis were carried out by means of Common component and specific weight analysis and multi-block partial least squares discriminant analysis, respectively. Stools collected during breastfeeding and during a mixed fruit/breastfeeding diet were characterized by high levels of fucosyl-oligosaccharides and glycolysis intermediates, including succinate and formate. The transition to a semi-solid food diet was characterized by several changes in fecal parameters: increase in short-chain fatty acids (SCFAs) levels, including acetate, propionate and butyrate, dissapearance of HMOs and the shift in the community composition, mainly occurring within the Firmicutes phylum. The variations in the fecal metabolome reflected the infant’s diet transition, while the composition of the microbiota followed a more complex and still unstable behavior.

scholarly journals The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration

2021 ◽  
Vol 12 ◽  
Author(s):  
Zhipeng Zheng ◽  
Baohong Wang
Keyword(s):  
Liver Injury ◽  
Gut Microbiota ◽  
Liver Regeneration ◽  
Liver Diseases ◽  
Molecular Mechanisms ◽  
Short Chain Fatty Acids ◽  
Pathophysiological Process ◽  
Tryptophan Metabolites ◽  
Health And Disease

Diverse liver diseases undergo a similar pathophysiological process in which liver regeneration follows a liver injury. Given the important role of the gut-liver axis in health and diseases, the role of gut microbiota-derived signals in liver injury and regeneration has attracted much attention. It has been observed that the composition of gut microbiota dynamically changes in the process of liver regeneration after partial hepatectomy, and gut microbiota modulation by antibiotics or probiotics affects both liver injury and regeneration. Mechanically, through the portal vein, the liver is constantly exposed to gut microbial components and metabolites, which have immense effects on the immunity and metabolism of the host. Emerging data demonstrate that gut-derived lipopolysaccharide, gut microbiota-associated bile acids, and other bacterial metabolites, such as short-chain fatty acids and tryptophan metabolites, may play multifaceted roles in liver injury and regeneration. In this perspective, we provide an overview of the possible molecular mechanisms by which gut microbiota-derived signals modulate liver injury and regeneration, highlighting the potential roles of gut microbiota in the development of gut microbiota-based therapies to alleviate liver injury and promote liver regeneration.

scholarly journals Gut Microbiota Metabolites in Major Depressive Disorder. Deep Insights into Their Pathophysiological Role and Potential Translational Applications

Metabolites ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 50
Author(s):  
Miguel A. Ortega ◽  
Miguel Angel Alvarez-Mon ◽  
Cielo García-Montero ◽  
Oscar Fraile-Martinez ◽  
Luis G. Guijarro ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Gut Microbiota ◽  
Depressive Disorder ◽  
Disease Status ◽  
Short Chain Fatty Acids ◽  
Human Organism ◽  
Microbial Metabolites ◽  
Clinical Value ◽  
Major Depressive ◽  
Health And Disease

The gut microbiota is a complex and dynamic ecosystem essential for the proper functioning of the organism, affecting the health and disease status of the individuals. There is continuous and bidirectional communication between gut microbiota and the host, conforming to a unique entity known as “holobiont”. Among these crosstalk mechanisms, the gut microbiota synthesizes a broad spectrum of bioactive compounds or metabolites which exert pleiotropic effects on the human organism. Many of these microbial metabolites can cross the blood–brain barrier (BBB) or have significant effects on the brain, playing a key role in the so-called microbiota-gut-brain axis. An altered Microbiota-Gut-Brain (MGB) axis is a major characteristic of many neuropsychiatric disorders, including major depressive disorder (MDD). Significative differences between gut eubiosis and dysbiosis in mental disorders like MDD with their different metabolite composition and concentrations are being discussed. In the present review, the main microbial metabolites (short-chain fatty acids -SCFAs-, bile acids, amino acids, tryptophan -trp- derivatives, and more), their signaling pathways and functions will be summarized to explain part of MDD pathophysiology. Conclusions from promising translational approaches related to microbial metabolome will be addressed in more depth to discuss their possible clinical value in the management of MDD patients.

scholarly journals Fecal Short Chain Fatty Acid ratios are related to both Depressive and Gastrointestinal Symptoms in Young Adults

2020 ◽  
Author(s):  
Bettina Müller ◽  
Annica J. Rasmusson ◽  
David Just ◽  
Shishanthi Jayarathna ◽  
Ali Moazzami ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Young Adults ◽  
Depressive Symptoms ◽  
Gut Microbiota ◽  
Depressive Disorders ◽  
Gastrointestinal Symptoms ◽  
Positive Association ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Chain Fatty Acids

AbstractObjectiveShort chain fatty acids (SCFAs) are produced by the gut microbiota and may reflect health. Gut symptoms are common in individuals with depressive disorders and recent data indicates relationships between gut microbiota and psychiatric health. We aimed to investigate potential associations between SCFAs and self-reported depressive and gut symptoms in young adults.MethodFecal samples from 164 individuals, of which 125 were patients with psychiatric disorders, were analyzed for the short chain fatty acids (SCFA) acetate, butyrate and propionate by nuclear magnetic resonance (NMR) spectroscopy. We then compared SCFA ratios to dimensional measures of self-reported depressive and gut symptoms.ResultsDepressive symptoms showed a positive association to acetate levels and negative associations to both butyrate and propionate levels in relation to total SCFA levels. Furthermore, symptoms of diarrhea and bloating showed positive associations to acetate and negative associations to propionate in relation to total SCFA levels. Cluster analysis revealed a heterogeneous pattern where shifts in SCFA ratios were seen for individuals with either elevated levels of depressive symptoms, elevated levels of gut symptoms or both.ConclusionShifts in SCFAs may have relevance for both depressive symptoms and gut symptoms in young adults.

scholarly journals Gut microbiota: The emerging link to lung homeostasis and disease

2020 ◽  
Author(s):  
An Zhou ◽  
Yuanyuan Lei ◽  
Li Tang ◽  
Shiping Hu ◽  
Min Yang ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Cross Talk ◽  
Lung Diseases ◽  
Disease Susceptibility ◽  
Short Chain Fatty Acids ◽  
Therapeutic Strategies ◽  
Point Of View ◽  
Health And Disease ◽  
Gut Microbiota Dysbiosis ◽  
Underlying Pathogenesis

The gut microbiota plays a crucial role in the development of the immune system and confers benefits or disease susceptibility to the host. Emerging studies have indicated that the gut microbiota could affect pulmonary health and disease through cross-talk between the gut microbiota and the lungs. Gut microbiota dysbiosis could lead to acute or chronic lung disease, such as asthma, tuberculosis and lung cancer. In addition, the composition of the gut microbiota may be associated with different lung diseases, the prevalence of which also vary by age. Modulation of the gut microbiota through short-chain fatty acids, probiotics and micronutrients may present potential therapeutic strategies to protect against lung diseases. In this review, we will provide an overview of the cross-talk between the gut microbiota and the lungs as well as elucidate the underlying pathogenesis or potential therapeutic strategies of some lung diseases from the point of view of the gut microbiota.

scholarly journals The Controversial Role of Human Gut Lachnospiraceae

2020 ◽  
Vol 8 (4) ◽  
pp. 573 ◽  
Author(s):  
Mirco Vacca ◽  
Giuseppe Celano ◽  
Francesco Maria Calabrese ◽  
Piero Portincasa ◽  
Marco Gobbetti ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Gut Microbiota ◽  
Short Chain Fatty Acids ◽  
Intestinal Lumen ◽  
Human Gut ◽  
The Core ◽  
Host Diet ◽  
Health And Disease ◽  
Host Physiology

The complex polymicrobial composition of human gut microbiota plays a key role in health and disease. Lachnospiraceae belong to the core of gut microbiota, colonizing the intestinal lumen from birth and increasing, in terms of species richness and their relative abundances during the host’s life. Although, members of Lachnospiraceae are among the main producers of short-chain fatty acids, different taxa of Lachnospiraceae are also associated with different intra- and extraintestinal diseases. Their impact on the host physiology is often inconsistent across different studies. Here, we discuss changes in Lachnospiraceae abundances according to health and disease. With the aim of harnessing Lachnospiraceae to promote human health, we also analyze how nutrients from the host diet can influence their growth and how their metabolites can, in turn, influence host physiology.

scholarly journals Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria

2021 ◽  
Vol 9 (3) ◽  
pp. 565
Author(s):  
Bernardo Cuffaro ◽  
Aka L. W. Assohoun ◽  
Denise Boutillier ◽  
Véronique Peucelle ◽  
Jérémy Desramaut ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Chronic Diseases ◽  
Short Chain Fatty Acids ◽  
Potential Health ◽  
High Prevalence ◽  
Bowel Diseases ◽  
Health Promoting ◽  
Health And Disease ◽  
Set Up ◽  
Functional Capacities

The role of the gut microbiota in health and disease is well recognized and the microbiota dysbiosis observed in many chronic diseases became a new therapeutic target. The challenge is to get a better insight into the functionality of commensal bacteria and to use this knowledge to select live biotherapeutics as new preventive or therapeutic products. In this study, we set up a screening approach to evaluate the functional capacities of a set of 21 strains isolated from the gut microbiota of neonates and adults. For this purpose, we selected key biological processes involved in the microbiome-host symbiosis and known to impact the host physiology i.e., the production of short-chain fatty acids and the ability to strengthen an epithelial barrier (Caco-2), to induce the release of the anti-inflammatory IL-10 cytokine after co-culture with human immune cells (PBMC) or to increase GLP-1 production from STC-1 endocrine cell line. This strategy highlighted fifteen strains exhibiting beneficial activities among which seven strains combined several of them. Interestingly, this work revealed for the first time a high prevalence of potential health-promoting functions among intestinal commensal strains and identified several appealing novel candidates for the management of chronic diseases, notably obesity and inflammatory bowel diseases.

scholarly journals The association of gut microbiota characteristics in Malawian infants with growth and inflammation

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Arox W. Kamng’ona ◽  
Rebecca Young ◽  
Charles D. Arnold ◽  
Emma Kortekangas ◽  
Noel Patson ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Head Circumference ◽  
Diversity Index ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Z Scores ◽  
Stool Samples ◽  
Independent Variable ◽  
Microbiota Diversity ◽  
Weight For Age

Abstract We tested the hypotheses that a more mature or diverse gut microbiota will be positively associated with infant growth and inversely associated with inflammation. We characterized gut microbiota from the stool samples of Malawian infants at 6 mo (n = 527), 12 mo (n = 632) and 18 mo (n = 629) of age. Microbiota diversity and maturity measurements were based on Shannon diversity index and microbiota for age Z-score (MAZ), respectively. Growth was calculated as change in Z-scores for weight-for-age (WAZ), length-for-age (LAZ) and head circumference-for-age (HCZ) from 6 to 12 mo and 12 to 18 mo. Biomarkers of inflammation (alpha-1-acid glycoprotein (AGP) and C-reactive protein (CRP)) were measured at 6 and 18 mo. Multivariable models were used to assess the association of each independent variable with each outcome. Microbiota diversity and maturity were related to growth in weight from 6 to 12 mo, but not to growth in length or head circumference or to growth from 12 to 18 mo. Microbiota diversity and maturity may also be linked to inflammation, but findings were inconsistent.

Sign in / Sign up

Export Citation Format

Share Document